久久99国产这里只有精品/欧美黄片大全/男生晚上睡不着想看点害羞的/小可爱免费直播下载 - 久色网

首頁 ? pCOLADuet-1圖譜序列抗性價格Biovector質粒庫

pCOLADuet-1圖譜序列抗性價格Biovector質粒庫

  • 價　　格：￥0
  • 貨　　號：39599052469
  • 產　　地：北京
點擊詢問我要采購
 竭誠為您服務！
BioVector NTCC典型培養物保藏中心
聯系人：Dr.Xu, Biovector NTCC Inc.

電話：400-800-2947 工作QQ:1843439339 (微信同號)

郵件：Biovector@163.com

手機：18901268599

地址：北京

已注冊
 

pCOLADuet1載體基本信息

出品公司:別名:質粒類型:表達水平:克隆方法:載體大小:5' 測序引物:5' 測序引物序列:  3' 測序引物:3' 測序引物序列:  載體標簽:載體抗性:備注:產品目錄號:穩定性:組成型:病毒/非病毒:
EMD Biosciences (Novagen)
pCOLADuet1, pCOLADuet 1
大腸桿菌蛋白雙表達載體，有兩個多克隆位點
高
多克隆位點，限制性內切酶
3719 bp
T7
T7: 5'-TAATACGACTCACTATAGGG-3';
T7t
T7t: 5'-TGCTAGTTATTGCTCAGCGG-3'
N-His, C-S
Kanamycin
pRSFDuet-1 carries the RSF1030 replicon, lacI gene and kanamycin resistance gene.
71406-3
瞬時表達 Transient
組成型 Constitutive
非病毒

pCOLADuet1載體質粒圖譜和多克隆位點信息

pCOLADuet-1載體圖譜
pCOLADuet-1多克隆位點

pCOLADuet1載體簡介

pCOLADuet-1 is designed for the coexpression of two target genes from a single plasmid. The vector encodes two multiple cloning sites (MCS) each of which is preceded by a T7 promoter, lac operator, and ribosome binding site (rbs). MCS-1 encodes the six-amino acid His•Tag sequence for the creation of a N-terminal fusion and MCS2 encodes the 15 amino acid S•Tag™ peptide after the last restriction site for the creation of a C-terminal fusion if desired. Genes inserted into MCS-1 can be sequenced using the ACYCDuetUP1 Primer and DuetDOWN1 Primer. Genes inserted into MCS-2 can be sequenced using the DuetUP2 Primer and T7 Terminator Primer. The vector has the COLA replicon from ColA(1) and the kanamycin resistance gene. This vector can be transformed into the same cell with plasmids containing compatible origins of replication and drug resistance genes for coexpression of up to 8 target genes.

pCOLADuet1載體序列

LOCUS       pCOLADuet-1    3719 bp     DNA  Circular   SYN
DEFINITION  pCOLADuet-1
ACCESSION   
KEYWORDS    
SOURCE      
  ORGANISM  other sequences; artificial sequences; vectors.
COMMENT     This file is created by Vector NTI
            http://www.biofeng.com/
COMMENT     ORIGDB|GenBank
COMMENT     VNTAUTHORNAME|biofeng.com|
COMMENT     VNTOAUTHORAD1|Novagen Inc.|
FEATURES             Location/Qualifiers
     source          1..3719
                     /organism="pCOLADuet-1"
                     /mol_type="other DNA"
     misc_feature    2..29
                     /label="lacO"
     promoter        214..232
                     /label="T7_promoter"
     misc_feature    232..259
                     /label="lacO"
     misc_feature    complement(448..466)
                     /label="T7_Terminal_primer"
     gene            complement(739..1554)
                     /label="KanR2"
                     /gene="KanR2"
     CDS             complement(739..1554)
                     /label="ORF frame 3"
                     /translation="MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLY
                     GKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIP
                     GKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL
                     VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG
                     RVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF*"
     promoter        complement(1596..1624)
                     /label="AmpR_promoter"
                     /translation="MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLY
                     GKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIP
                     GKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL
                     VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG
                     RVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF*"
     misc_feature    complement(2497..3588)
                     /label="lacI"
                     /translation="MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLY
                     GKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIP
                     GKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL
                     VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG
                     RVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF*"
     CDS             complement(2497..3456)
                     /label="ORF frame 3"
                     /translation="MAELNYIPNRVAQQLAGKQSLLIGVATSSLALHAPSQIVAAIKS
                     RADQLGASVVVSMVERSGVEACKAAVHNLLAQRVSGLIINYPLDDQDAIAVEAACTNV
                     PALFLDVSDQTPINSIIFSHEDGTRLGVEHLVALGHQQIALLAGPLSSVSARLRLAGW
                     HKYLTRNQIQPIAEREGDWSAMSGFQQTMQMLNEGIVPTAMLVANDQMALGAMRAITE
                     SGLRVGADISVVGYDDTEDSSCYIPPLTTIKQDFRLLGQTSVDRLLQLSQGQAVKGNQ
                     LLPVSLVKRKTTLAPNTQTASPRALADSLMQLARQVSRLESGQ*"
     CDS             complement(3329..158)
                     /label="ORF frame 1"
                     /translation="MRPQACRPAGAPSSNSDPGCGDDGDGCCPWYISLLKLNKIISTG
                     ELLSAHNSPIVSRINFLMQESHKGERRDPGHHRMAQNLSRYGMIAPGRESIQGGECET
                     SNVIRCRRVCRCLLSDRFPRGEPGQPRFCENAGKSGSGDGGAELHSQPRGTTTGGQTV
                     VADWRCHLQSGPARAVANCRGD*"
     promoter        3703..2
                     /label="T7_promoter"
                     /translation="MRPQACRPAGAPSSNSDPGCGDDGDGCCPWYISLLKLNKIISTG
                     ELLSAHNSPIVSRINFLMQESHKGERRDPGHHRMAQNLSRYGMIAPGRESIQGGECET
                     SNVIRCRRVCRCLLSDRFPRGEPGQPRFCENAGKSGSGDGGAELHSQPRGTTTGGQTV
                     VADWRCHLQSGPARAVANCRGD*"
ORIGIN
    1 ggggaattgt gagcggataa caattcccct gtagaaataa ttttgtttaa ctttaataag
   61 gagatatacc atgggcagca gccatcacca tcatcaccac agccaggatc cgaattcgag
  121 ctcggcgcgc ctgcaggtcg acaagcttgc ggccgcataa tgcttaagtc gaacagaaag
  181 taatcgtatt gtacacggcc gcataatcga aattaatacg actcactata ggggaattgt
  241 gagcggataa caattcccca tcttagtata ttagttaagt ataagaagga gatatacata
  301 tggcagatct caattggata tcggccggcc acgcgatcgc tgacgtcggt accctcgagt
  361 ctggtaaaga aaccgctgct gcgaaatttg aacgccagca catggactcg tctactagcg
  421 cagcttaatt aacctaggct gctgccaccg ctgagcaata actagcataa ccccttgggg
  481 cctctaaacg ggtcttgagg ggttttttgc tgaaacctca ggcatttgag aagcacacgg
  541 tcacactgct tccggtagtc aataaaccgg taaaccagca atagacataa gcggctattt
  601 aacgaccctg ccctgaaccg acgacaagct gacgaccggg tctccgcaag tggcactttt
  661 cggggaaatg tgcgcggaac ccctatttgt ttatttttct aaatacattc aaatatgtat
  721 ccgctcatga attaattctt agaaaaactc atcgagcatc aaatgaaact gcaatttatt
  781 catatcagga ttatcaatac catatttttg aaaaagccgt ttctgtaatg aaggagaaaa
  841 ctcaccgagg cagttccata ggatggcaag atcctggtat cggtctgcga ttccgactcg
  901 tccaacatca atacaaccta ttaatttccc ctcgtcaaaa ataaggttat caagtgagaa
  961 atcaccatga gtgacgactg aatccggtga gaatggcaaa agtttatgca tttctttcca
 1021 gacttgttca acaggccagc cattacgctc gtcatcaaaa tcactcgcat caaccaaacc
 1081 gttattcatt cgtgattgcg cctgagcgag acgaaatacg cggtcgctgt taaaaggaca
 1141 attacaaaca ggaatcgaat gcaaccggcg caggaacact gccagcgcat caacaatatt
 1201 ttcacctgaa tcaggatatt cttctaatac ctggaatgct gttttcccgg ggatcgcagt
 1261 ggtgagtaac catgcatcat caggagtacg gataaaatgc ttgatggtcg gaagaggcat
 1321 aaattccgtc agccagttta gtctgaccat ctcatctgta acatcattgg caacgctacc
 1381 tttgccatgt ttcagaaaca actctggcgc atcgggcttc ccatacaatc gatagattgt
 1441 cgcacctgat tgcccgacat tatcgcgagc ccatttatac ccatataaat cagcatccat
 1501 gttggaattt aatcgcggcc tagagcaaga cgtttcccgt tgaatatggc tcatactctt
 1561 cctttttcaa tattattgaa gcatttatca gggttattgt ctcatgagcg gatacatatt
 1621 tgaatgtatt tagaaaaata aacaaatagg catgctagcg cagaaacgtc ctagaagatg
 1681 ccaggaggat acttagcaga gagacaataa ggccggagcg aagccgtttt tccataggct
 1741 ccgcccccct gacgaacatc acgaaatctg acgctcaaat cagtggtggc gaaacccgac
 1801 aggactataa agataccagg cgtttccccc tgatggctcc ctcttgcgct ctcctgttcc
 1861 cgtcctgcgg cgtccgtgtt gtggtggagg ctttacccaa atcaccacgt cccgttccgt
 1921 gtagacagtt cgctccaagc tgggctgtgt gcaagaaccc cccgttcagc ccgactgctg
 1981 cgccttatcc ggtaactatc atcttgagtc caacccggaa agacacgaca aaacgccact
 2041 ggcagcagcc attggtaact gagaattagt ggatttagat atcgagagtc ttgaagtggt
 2101 ggcctaacag aggctacact gaaaggacag tattt

您正在向 biovector.net  發送關于產品 pCOLADuet-1圖譜序列抗性價格Biovector質粒庫 的詢問

點擊“立即發送”后，我們將在1個工作日內與您取得聯系。